Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 71335-2505

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 71335-2505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-2 (Figure 2)

A line chart depicting the percent maintenance of response over six months for four groups: Esomeprazole Magnesium Delayed-Release Capsules at 40 mg, 20 mg, 10 mg, and a placebo group. The y-axis represents percent maintained, ranging from 0 to 100%, and the x-axis represents months from 0 to 6. The chart shows higher maintenance percentages for higher doses of Esomeprazole compared to placebo.*

FDA Label Image

Figure-3 (Figure 3)

A line graph depicting percent maintained over a 6-month period for different groups taking Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, 10 mg doses, and a placebo group. The x-axis represents months, and the y-axis represents percent maintained. Multiple lines show trends for each group over time.*

FDA Label Image

Figure-4 (Figure 4)

A line graph showing the percent of patients symptom-free over 28 days of diary tracking, comparing Esomeprazole Magnesium Delayed-Release Capsules at 20 mg and 40 mg doses against placebo. The y-axis represents the percentage of symptom-free patients, and the x-axis shows diary days from 0 to 28. Both dosages demonstrate higher symptom-free percentages than placebo throughout the period.*

FDA Label Image

Figure-5 (Figure 5)

A line graph comparing the percentage of patients symptom-free over 28 diary days for Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The graph shows the 40 mg and 20 mg doses with higher symptom-free percentages than placebo throughout the period.*

FDA Label Image

Ink1 (Ink1)

Esomeprazole Magnesium delayed-release capsules in a blister pack with individual capsules visible. The capsules appear to have a two-tone color scheme, but no text or imprints on the capsules are legible. The pack is intended for oral administration and produced by Bryant Ranch Prepack.*

FDA Label Image

Ink2 (Ink2)

Esomeprazole Magnesium 20 mg delayed-release capsules, packaged in a blister card with 7 capsules. The packaging shows the brand name and dosage strength, with capsules in transparent sections of the blister. Labeler Bryant Ranch Prepack is identified on the package.*

FDA Label Image

Label (Lbl713352505)

Label for Esomeprazole Magnesium delayed-release capsules, USP, 20 mg strength. The label states the product contains 30 capsules, is prescription only, and is repackaged by Bryant Ranch Prepack, Inc., with manufacturing by Yichang Humanwell Oral Solid Dosage Plant. It includes storage instructions, child-resistant packaging note, barcodes, and a QR code for the package insert.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of esomeprazole magnesium, showing its molecular components including pyridine, methoxybenzimidazole rings, and magnesium ion complexed with three water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.